CytRx Settles Investor Claims Over 'Spring-Loaded' Options
Biopharmaceutical firm CytRx Corp.'s brass agreed late Monday to settle derivative claims over alleged "spring-loaded" stock options with a deal to reprice most of the options board members were accused of...To view the full article, register now.
Already a subscriber? Click here to view full article